BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6182065)

  • 1. Persistent spontaneous heparinaemia in systemic mastocytosis.
    Nenci GG; Berrettini M; Parise P; Agnelli G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):453-63. PubMed ID: 6182065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized mastocytosis in a foal, resembling urticaria pigmentosa of man.
    Prasse KW; Lundvall RL; Cheville NF
    J Am Vet Med Assoc; 1975 Jan; 166(1):68-70. PubMed ID: 1089100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic mastocytosis associated to thrombopathy. Ultrastructural findings].
    Merino J; Recio M; Benet I; Sedano C; Val F; García-Conde J
    Rev Clin Esp; 1978 Oct; 151(2):149-53. PubMed ID: 740984
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin assay: a comparison between titrimetric and amidolytic methods.
    Nenci GG; Berrettini M; Agnelli G; Parise P
    Boll Soc Ital Biol Sper; 1980 Mar; 56(5):519-25. PubMed ID: 7387799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological, cytochemical and ultrastructural studies of a case of systemic mastocytosis.
    Malfitano A; Minoli L; Invernizzi R; Lanzarini P; Tinelli M; Rondanelli EG
    Basic Appl Histochem; 1983; 27(3):183-90. PubMed ID: 6196017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the reaction of blood coagulation in urticaria pigmentosa].
    Johannsen L; Künzer W
    Arch Kinderheilkd; 1966 May; 174(2):133-46. PubMed ID: 5299522
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis: a diagnostic challenge.
    Bateman HE; Shroff V; Centeno LV; Bielory L
    Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic mastocytosis. Apropos of a case].
    Rivero-Puente A; Borda F; Uribarrena R; Sauras MA; Sánchez J; Puras A; Peñuela JM; Montes M; Giralt M
    Rev Clin Esp; 1984 Dec 15-31; 175(5-6):237-9. PubMed ID: 6535208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow pathology in 5 cases of systemic mastocytosis. Pseudomyelomatous forms with dysglobulinemia and benign polyclonal bone marrow plasmacytosis. Hamazaki-Wesenberg bodies associated with mast cell granulomas].
    Kermarec J; Canioni D; Zafisaona G
    Arch Anat Cytol Pathol; 1983; 31(1):11-8. PubMed ID: 6859948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of systemic mastocytosis].
    Gromnatskiĭ NI; Gurevich PS; Kaplinskaia AI
    Klin Med (Mosk); 1980 May; 58(5):103-4. PubMed ID: 7382379
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the relations between serum complement and heparinemia in mastocytosis].
    Sbano E; Andreassi L; Valentino A
    G Ital Dermatol Minerva Dermatol; 1971 Nov; 46(11):492-6. PubMed ID: 5171288
    [No Abstract]   [Full Text] [Related]  

  • 18. [A clinical constelation in disuse: vitiligo, mastocytosis of the bone marrow, circulating heparinoid, chronic leg ulcer, hypoalbuminemia, ulcerative colitis and hepatic fibrosis].
    Goihman Yahr M; Goldstein C; González Y; Aranzazu N; Convit J; Acevedo Gallegos F; Grases P
    Med Cutan Ibero Lat Am; 1977; 5(4):229-34. PubMed ID: 82679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin activity in systemic mastocytosis.
    Campbell EW; Hector D; Gossain V
    Ann Intern Med; 1979 Jun; 90(6):940-1. PubMed ID: 312616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteosclerosis associated with systemic mastocytosis].
    Rosinus V
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1980-7. PubMed ID: 7280611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.